Chimeric Antigen Receptor T (CAR T) Therapy Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
CITY, Country, 2019-Jul-16 — /EPR Network/ — Chimeric antigen receptor T (CAR T) therapy is designed with a single signaling domain. CAR T therapy is [read full press release…]
